Tekla Capital Management LLC
Filing Date
Global Rank
#831
/ 6,901
▼ 47
· as of Jun 2023
Top Industry
Drug Manufacturers - General
35.6%
3Y Alpha vs SPY
-9.0%
Period ended 3 years ago
Filed Aug 10, 2023 · 2y
14 quarters · since Mar 2020
Clone Performance
Jul 2023–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+40.1%
SPY
+76.0%
Annualised alpha
-8.8%
Max drawdown
−17.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
127 positions · as of Jun 30, 2023 · Δ vs Mar 31, 2023Top Position
5.9%
+0.2 pts
Top 5
26.0%
+0.4 pts
Top 10
44.5%
+0.4 pts
HHI
273
Diversified−2
Portfolio Trend
14 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2023| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 98.3% | $2,274,023,744 |
| Real Estate | 1.7% | $40,430,770 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
24 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| BAX | Baxter International Inc | +257,058 | 324,370 | $14,778,297 | |
| IMVT | Immunovant, Inc. | +220,800 | 336,200 | $6,377,714 | |
| FULC | Fulcrum Therapeutics, Inc. | +198,351 | 256,888 | $847,730 | |
| PCVX | Vaxcyte, Inc. | +189,232 | 194,232 | $9,699,946 | |
| MRK | Merck & Co., Inc. | +176,032 | 728,154 | $84,021,690 | |
| BSX | Boston Scientific Corp | +91,800 | 657,790 | $35,579,861 | |
| AMGN | Amgen Inc | +60,600 | 616,539 | $136,883,988 | |
| IQV | Iqvia Holdings Inc. | +46,012 | 109,129 | $24,528,925 | |
| LIVN | LivaNova PLC | +44,600 | 108,480 | $5,579,126 | |
| APLS | Apellis Pharmaceuticals, Inc. | +38,124 | 173,248 | $15,782,892 | |
| DHR | Danaher Corp /De/ | +37,123 | 142,813 | $30,385,750 | |
| ABBV | AbbVie Inc. | +34,030 | 545,629 | $73,512,595 | |
| TCMD | Tactile Systems Technology Inc | +24,040 | 58,472 | $1,457,706 | |
| MDGL | Madrigal Pharmaceuticals, Inc. | +21,953 | 34,434 | $7,954,254 | |
| MRNA | Moderna, Inc. | +21,478 | 343,695 | $41,758,942 | |
| EW | Edwards Lifesciences Corp | +18,451 | 189,597 | $17,884,685 | |
| REGN | Regeneron Pharmaceuticals, Inc. | +18,365 | 161,418 | $115,985,289 | |
| MEDP | Medpace Holdings, Inc. | +17,483 | 26,918 | $6,464,896 | |
| ASND | Ascendis Pharma A/S | +15,000 | 138,791 | $12,387,096 | |
| NVO | Novo Nordisk A S | +11,454 | 122,777 | $9,934,500 | |
| SYK | Stryker Corp | +9,550 | 81,128 | $24,751,341 | |
| BIIB | Biogen Inc. | +7,017 | 247,943 | $70,626,563 | |
| TMO | Thermo Fisher Scientific Inc. | +5,282 | 98,987 | $51,646,467 | |
| PHG | Koninklijke Philips NV | +4,905 | 114,765 | $2,489,252 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
25 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| QURE | uniQure N.V. | −296,166 | 356,280 | $4,082,968 | |
| BMY | Bristol Myers Squibb Co | −205,298 | 458,498 | $29,320,947 | |
| PFE | Pfizer Inc | −150,600 | 1,624,476 | $59,585,779 | |
| GH | Guardant Health, Inc. | −126,100 | 346,084 | $12,389,807 | |
| SRPT | Sarepta Therapeutics, Inc. | −106,216 | 179,437 | $20,549,125 | |
| BMRN | Biomarin Pharmaceutical Inc | −89,300 | 210,789 | $18,271,190 | |
| CI | Cigna Group | −86,292 | 96,339 | $27,032,723 | |
| ACHC | Acadia Healthcare Company, Inc. | −85,575 | 100,912 | $8,036,631 | |
| LLY | ELI LILLY & Co | −75,565 | 213,352 | $100,057,820 | |
| ABT | Abbott Laboratories | −71,400 | 552,455 | $60,228,644 | |
| EWTX | Edgewise Therapeutics, Inc. | −44,607 | 150,418 | $1,165,739 | |
| BCYC | Bicycle Therapeutics PLC | −44,338 | 44,338 | $1,131,505 | |
| RMD | Resmed Inc | −38,485 | 34,704 | $7,582,824 | |
| CRSP | CRISPR Therapeutics AG | −32,509 | 22,571 | $1,267,135 | |
| ISRG | Intuitive Surgical Inc | −28,700 | 83,980 | $28,716,121 | |
| UNH | Unitedhealth Group Inc | −27,212 | 206,961 | $99,473,735 | |
| GILD | Gilead Sciences, Inc. | −26,000 | 1,533,884 | $118,216,439 | |
| NTRA | Natera, Inc. | −24,636 | 24,636 | $1,198,787 | |
| ARGX | Argenx SE | −22,757 | 65,553 | $25,547,970 | |
| UTHR | UNITED THERAPEUTICS Corp | −19,735 | 41,465 | $9,153,398 | |
| XENE | Xenon Pharmaceuticals Inc. | −16,208 | 67,506 | $2,598,981 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −12,300 | 318,043 | $111,922,512 | |
| ILMN | Illumina, Inc. | −11,100 | 336,979 | $61,459,342 | |
| CRL | Charles River Laboratories International, Inc. | −6,900 | 111,183 | $23,376,225 | |
| HCA | HCA Healthcare, Inc. | −6,300 | 82,403 | $25,007,662 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
6 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PODD | Insulet Corp | 43,847 | $12,642,843 | |
| THC | Tenet Healthcare Corp | 149,070 | $12,131,316 | |
| INSP | Inspire Medical Systems, Inc. | 22,018 | $7,147,923 | |
| AMLX | Amylyx Pharmaceuticals, Inc. | 104,007 | $2,243,430 | |
| XNCR | Xencor Inc | 56,675 | $1,415,174 | |
| ZNTL | Zentalis Pharmaceuticals, Inc. | 40,156 | $1,132,800 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
11 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | 418,520 | $9,412,514 | |
| LNTH | Lantheus Holdings, Inc. | 79,495 | $6,563,107 | |
| ADUS | Addus HomeCare Corp | 42,380 | $4,524,488 | |
| KURA | Kura Oncology, Inc. | 283,281 | $3,464,526 | |
| RARE | Ultragenyx Pharmaceutical Inc. | 67,065 | $2,689,306 | |
| ARWR | Arrowhead Pharmaceuticals, Inc. | 100,422 | $2,550,718 | |
| SNDX | Syndax Pharmaceuticals Inc | 117,717 | $2,486,183 | |
| ALGN | Align Technology Inc | 6,925 | $2,313,919 | |
| OPCH | Option Care Health, Inc. | 64,975 | $2,064,255 | |
| ZLAB | Zai Lab Ltd | 34,640 | $1,152,126 | |
| BHVN | Biohaven Ltd. | 35,087 | $479,288 | |
| No positions match the current search. | ||||
127 positions ·
$2,314,454,514 total
· as of Jun 30, 2023
Showing 1–50
of 127 positions by value
· page 1 of 3
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| AMGN |
Amgen Inc
Healthcare
|
Added | 616,539 | $136,883,988 | 5.91% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Held | 721,779 | $119,468,860 | 5.16% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Reduced | 1,533,884 | $118,216,439 | 5.11% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Added | 161,418 | $115,985,289 | 5.01% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 318,043 | $111,922,512 | 4.84% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Reduced | 213,352 | $100,057,820 | 4.32% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Reduced | 206,961 | $99,473,735 | 4.30% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Added | 728,154 | $84,021,690 | 3.63% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Added | 545,629 | $73,512,595 | 3.18% | |
| BIIB |
Biogen Inc.
Healthcare
|
Added | 247,943 | $70,626,563 | 3.05% | |
| ILMN |
Illumina, Inc.
Healthcare
|
Reduced | 336,979 | $61,459,342 | 2.66% | |
| ABT |
Abbott Laboratories
Healthcare
|
Reduced | 552,455 | $60,228,644 | 2.60% | |
| PFE |
Pfizer Inc
Healthcare
|
Reduced | 1,624,476 | $59,585,779 | 2.57% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Added | 98,987 | $51,646,467 | 2.23% | |
| ELV |
Elevance Health, Inc.
Healthcare
|
Held | 114,070 | $50,680,160 | 2.19% | |
| MRNA |
Moderna, Inc.
Healthcare
|
Added | 343,695 | $41,758,942 | 1.80% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 657,790 | $35,579,861 | 1.54% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Added | 142,813 | $30,385,750 | 1.31% | |
| MDT |
Medtronic plc
Healthcare
|
Reduced | 344,417 | $30,343,137 | 1.31% | |
| IDXX |
Idexx Laboratories Inc /De
Healthcare
|
Held | 58,595 | $29,428,166 | 1.27% | |
| DXCM |
Dexcom Inc
Healthcare
|
Held | 228,747 | $29,396,276 | 1.27% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Reduced | 458,498 | $29,320,947 | 1.27% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Reduced | 83,980 | $28,716,121 | 1.24% | |
| ALNY |
Alnylam Pharmaceuticals, Inc.
Healthcare
|
Held | 143,214 | $27,202,067 | 1.18% | |
| CI |
Cigna Group
Healthcare
|
Reduced | 96,339 | $27,032,723 | 1.17% | |
| MCK |
Mckesson Corp
Healthcare
|
Reduced | 61,955 | $26,473,991 | 1.14% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 65,553 | $25,547,970 | 1.10% | |
| HCA |
HCA Healthcare, Inc.
Healthcare
|
Reduced | 82,403 | $25,007,662 | 1.08% | |
| SYK |
Stryker Corp
Healthcare
|
Added | 81,128 | $24,751,341 | 1.07% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 109,129 | $24,528,925 | 1.06% | |
| ZTS |
Zoetis Inc.
Healthcare
|
Held | 136,914 | $23,577,959 | 1.02% | |
| CRL |
Charles River Laboratories International, Inc.
Healthcare
|
Reduced | 111,183 | $23,376,225 | 1.01% | |
| SRPT |
Sarepta Therapeutics, Inc.
Healthcare
|
Reduced | 179,437 | $20,549,125 | 0.89% | |
| MOH |
Molina Healthcare, Inc.
Healthcare
|
Held | 61,856 | $18,633,501 | 0.81% | |
| JAZZ |
Jazz Pharmaceuticals plc
Healthcare
|
Held | 147,779 | $18,320,162 | 0.79% | |
| BMRN |
Biomarin Pharmaceutical Inc
Healthcare
|
Reduced | 210,789 | $18,271,190 | 0.79% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Added | 189,597 | $17,884,685 | 0.77% | |
| HUM |
Humana Inc
Healthcare
|
Held | 36,794 | $16,451,701 | 0.71% | |
| APLS |
Apellis Pharmaceuticals, Inc.
Healthcare
|
Added | 173,248 | $15,782,892 | 0.68% | |
| BAX |
Baxter International Inc
Healthcare
|
Added | 324,370 | $14,778,297 | 0.64% | |
| EXEL |
Exelixis, Inc.
Healthcare
|
Held | 726,639 | $13,886,071 | 0.60% | |
| NVS |
Novartis AG
Healthcare
|
Held | 136,225 | $13,746,464 | 0.59% | |
| PODD |
Insulet Corp
Healthcare
|
NEW | 43,847 | $12,642,843 | 0.55% | |
| GH |
Guardant Health, Inc.
Healthcare
|
Reduced | 346,084 | $12,389,807 | 0.54% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 138,791 | $12,387,096 | 0.54% | |
| THC |
Tenet Healthcare Corp
Healthcare
|
NEW | 149,070 | $12,131,316 | 0.52% | |
| BNTX |
BioNTech SE
Healthcare
|
Held | 103,858 | $11,209,393 | 0.48% | |
| NBIX |
Neurocrine Biosciences Inc
Healthcare
|
Held | 112,908 | $10,647,224 | 0.46% | |
| NVO |
Novo Nordisk A S
Healthcare
|
Added | 122,777 | $9,934,500 | 0.43% | |
| ZBH |
Zimmer Biomet Holdings, Inc.
Healthcare
|
Held | 67,356 | $9,807,033 | 0.42% |